CELL AND GENE THERAPY MANUFACTURING
A CDMO Perspective: Bioprocess Automation And Data Management
Watch this video to understand data management and process automation challenges across single-use bioprocessing applications from a CDMO leader, Paul Jorjorian, VP and GM of Pharma Services at Thermo Fisher Scientific.
Accelerating Bioprocessing Success With Analytics
This bioprocessing online webinar series talks about analytical solutions to help accelerate bioprocessing success. There are a variety of analytical options available to help you gain deeper insights on your cell culture process.
AAV Purification: Solving Downstream Challenges
In this roundtable discussion, a trio of distinguished experts in AAV purification and process development share their expertise and best practices in tackling and solving downstream challenges.
Simple In-House Mycoplasma Testing Method For Regulatory Expectations And Rapid, Confident, And Actionable Results
In this webinar, we present an overview of worldwide regulatory guidance for mycoplasma testing, as well as a mycoplasma testing method that has been accepted by regulatory authorities worldwide across various therapeutic modalities.
How To Fill And Empty Nunc Standard Cell Factory System
Watch this step by step how to instructional video to learn how to fill and empty the Thermo Scientific Nunc Standard Cell Factory System, which is compatible with the same cell culture techniques used in smaller cell culture vessels.
Enabling Assurance Of Supply Through Evolving Bioprocessing Needs
This featured event at the Gibco cell culture media 60th-anniversary in Grand Island, New York spotlights proactive strategies used by Thermo Fisher Scientific to decrease risk, ensure quality and meet customers raw material needs worldwide.
Advancing Vaccine Development With Novel Chromatography Solutions & Quality Testing
Learn more on novel chromatography solutions that can help improve the downstream processes of different vaccine types such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).
Manufacturing Considerations For Viral & Non-Viral Platform Selection
In this webinar, a panel of experts spanning the lentiviral vector, exosome and oncolytic virus fields will discuss the impact of manufacturing considerations on their respective platform selection and ongoing product/process development strategies.
Thermo Fisher Scientific Suzhou, China Manufacturing Site Capabilities
Watch this video to learn more about this manufacturing site capabilities, quality management systems, PPI implementation, product expansion, assurance of supply and lead times.
Mitigating Risk In Process Automation
Two Chief Technical Officer's for therapeutic organizations cover the various ways in which automation helps to reduce risk and why closing systems and reducing the number of manual manipulations is so critical.
Regulatory Compliance And Viral Vectors
Hear from experts who detail the specific regulatory challenges for advanced therapies, as well as how the regulatory requirements differ in early research and development in academia and in industrial vector production.
Why Clinical Requirements Change: Dr. Peter Marks on Pre-IND Meeting Pathways
Learn how clinical requirements change after the FDA and a company agree on a pathway during a pre-IND meeting and how the company might recover as a result.
Race To The Regulatory Finish Line: Dr. Nicole Verdun Talks Efficiencies In Platform Technologies
Could a platform approach help certain therapies make their way over the regulatory finish line more efficiently?
Analytical Solutions To Help Accelerate Bioprocessing Success
Unlock the power of data-driven bioprocessing. Discover how advanced analytics can optimize your cell culture process, improve performance, and accelerate success.
Advancing Gene Therapy Development With A Multi-Serotype AAV Resin
In this webinar, leading CDMO ABL and Thermo Fisher will share data on implementation of the POROS™ CaptureSelect™ AAVX affinity resin into such an AAV purification platform, including its performance in purifying several serotypes.
Patient Data's Impact On CMC Robustness
When CGT products demonstrate dramatic improvements with minimal safety concerns in a Phase 2 study, sponsors may want to modify the protocol mid-study to increase patient enrollment.
Isolating CD4 / CD8 T Cells For Improved Drug Efficacy, Productivity
Learn how the active detachment of dynabeads from target cells at any time allows users to add flexibility and scalability to their process.
Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview
From lab to production scale: a researcher's firsthand account of what bioreactor scaling and high-density perfusion really demand in practice.
Enhanced Chromatography Resins For Faster, More Efficient Purification
Learn from an industry veteran about the evolution of protein purification, from early equipment to modern, agile solutions, emphasizing continuous improvement and customer-centric approaches.
CAR-T Innovation: Balancing Allogeneic And Autologous Cell Therapy
Join experts as they discuss strategies for optimizing allogeneic and autologous therapies, aiming for balanced development and wider patient accessibility by 2030.
CaptureSelect™ Technology - Powerful Affinity For More Streamlined Purification
Replace inefficient chromatographic steps with high-specificity affinity ligands to streamline downstream processing. This approach simplifies workflows and protects sensitive biomolecules.
Quality Control Assays
Two company leaders detail not only the vectors their respective companies use and why but also the quality control assays performed on viral vectors.
Speed Up Process Development With HTS Tools For Affinity Chromatography
High Throughput Screening (HTS) chromatography tools can accelerate process development and reduce material usage. Learn about a solution that addresses challenges with their use in new modalities.
Safety And Efficiency Of Source Material Collection
Expert CTO's detail how automation improves safety and efficiency when collecting source material.
BPI Interviews Purification And Pharma Analytics Leader
Jean Luo, VP of Purification and Pharma Analytics, discusses innovations in bioprocessing, including the development of dPCR assays, lentiviral titer systems, chromatography resins, and supply chain.
Tackling Residual DNA Testing In Biotherapy Manufacturing
Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.
Setup Made Simple With The BioTitan Retention Device
Find out how quick and simple it is to set up an assembly secured with the Thermo Scientific BioTitan Retention Device.
A Collaboration With Zurich University Of Applied Sciences
Explore ZHAW’s pioneering work and collaboration in cell cultivation and bioprocessing to deliver scalable, high-performance solutions that address key challenges in biomanufacturing scale-up.
Accelerating Process Scale-Up From Benchtop To Commercialization- From Controller To Software
Discover strategies for optimizing process control, refining media selection, and ensuring safety through rigorous contaminant detection to mitigate development risks.
Multi-Omics And Bioinformatics In Cell Culture Media Design
Learn about the impact of a multi-omics analysis, utilizing proteomics and metabolomics, in the development and optimization of media with the goal of improving titer, and making development and manufacturing more efficient.